null
ChEBI ID: 47020
| Member | Definition | Role |
|---|---|---|
| amprenavir | amprenavir |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 96 (18.15) | 18.2507 |
| 2000's | 318 (60.11) | 29.6817 |
| 2010's | 99 (18.71) | 24.3611 |
| 2020's | 16 (3.02) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 91 (16.40%) | 5.53% |
| Reviews | 34 (6.13%) | 6.00% |
| Case Studies | 16 (2.88%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 414 (74.59%) | 84.16% |